Bottom line
PPH vs IXJ: the short answer
PPH (VanEck Pharmaceutical ETF) and IXJ (iShares Global Healthcare ETF) are both etfs.
But IXJ is far broader, holding 124 positions to 26 for PPH, so beyond the top names it adds exposure PPH doesn't have.
PPH is cheaper at 0.36% vs 0.38% — a difference of $2.00 a year per $10,000 invested.
Over five years, PPH returned +11.3% a year vs +6.4% for IXJ.
Updated Nov 19, 2026
PPH vs IXJ side by side
| PPH | IXJ | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | VanEck | iShares |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.36% | 0.38% |
| Annual cost per $10k | $36 | $38 |
| 10-yr cost on $10k (prospectus) | $456 | $480 |
| Max front load | None | None |
| 12b-1 fee | — | 0% |
| 1-yr return | +21.9% | +14.9% |
| 5-yr return (annualized) | +11.3% | +6.4% |
| 10-yr return (annualized) | +6.7% | +8.2% |
| Best quarter | +16.5% | +13.6% |
| Worst quarter | −15.0% | −11.8% |
| Net assets (fund) | $879.5M | $3.8B |
| Number of holdings | 26 | 124 |
| Portfolio turnover | 3% | 2% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | PPH | IXJ | Difference |
|---|---|---|---|
| 2025 | +21.9% | +14.9% | +7.1% |
| 2024 | +8.1% | +0.6% | +7.5% |
| 2023 | +6.9% | +3.5% | +3.4% |
| 2022 | +2.6% | −4.7% | +7.3% |
| 2021 | +18.3% | +19.5% | −1.2% |
| 2020 | +5.2% | +12.5% | −7.3% |
| 2019 | +19.1% | +23.4% | −4.2% |
| 2018 | −5.7% | +2.9% | −8.5% |
| 2017 | +15.4% | +20.3% | −4.9% |
| 2016 | −17.8% | −6.2% | −11.6% |
Source: Fund prospectus bar charts
Holdings overlap
8 of PPH's top 25 holdings also appear in IXJ's top 25.
| Holding | PPH | IXJ |
|---|---|---|
| Eli Lilly & Co | 20.23% | 10.93% |
| Merck & Co Inc | 9.85% | 4.12% |
| AbbVie Inc | 4.57% | 5.12% |
| Pfizer Inc | 4.51% | 1.78% |
| Bristol-Myers Squibb Co | 4.47% | 1.53% |
| Johnson & Johnson | 4.35% | 7.04% |
| AstraZeneca PLC | 4.33% | 3.76% |
| McKesson Corp | 4.12% | 1.18% |
Source: SEC Form N-PORT
PPH top 10
- Eli Lilly & Co — 20.23%
- Novartis AG — 10.63%
- Merck & Co Inc — 9.85%
- Novo Nordisk A/S — 5.37%
- AbbVie Inc — 4.57%
- Pfizer Inc — 4.51%
- Bristol-Myers Squibb Co — 4.47%
- Gsk Plc — 4.42%
- Johnson & Johnson — 4.35%
- AstraZeneca PLC — 4.33%
IXJ top 10
- Eli Lilly And Company — 10.93%
- Johnson & Johnson — 7.04%
- Abbvie Inc. — 5.12%
- Unitedhealth Group Incorporated — 4.40%
- Merck & Co., Inc. — 4.12%
- Astrazeneca Plc — 3.76%
- Roche Holding AG — 3.75%
- Novartis AG — 3.71%
- Amgen Inc. — 2.54%
- Thermo Fisher Scientific Incorporated — 2.42%
FAQ
What is the difference between PPH and IXJ?
Which is cheaper, PPH or IXJ?
Should I own both PPH and IXJ?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.